Skip to main content Accessibility help

Is low-dose intratympanic gentamicin an effective treatment for Ménière's disease: the Birmingham experience

  • G J Watson (a1), C Nelson (a2) and R M Irving (a1)



Since the development of intratympanic aminoglycoside in the 1950s, otologists have been able to chemically ablate the vestibule. We present the results of using low-dose intratympanic gentamicin to treat Ménière's disease.


A retrospective review was performed of all patients who underwent low-dose intratympanic gentamicin therapy over seven years. Data on gender, age, number of procedures, pure tone audiometry and symptom control were analysed.


In all, 38 patients underwent low-dose intratympanic gentamicin therapy. These comprised 25 females and 13 males, with an average age of 58.4 years. Hearing was preserved in 87.5 per cent of patients, with no significant difference before and after treatment (p = 0.744). In all, 85.7 per cent of patients had complete or substantial symptom control (classes A and B, respectively).


Low-dose intratympanic gentamicin therapy was effective in controlling the symptoms of Ménière's disease patients, while preserving hearing.


Corresponding author

Address for correspondence: Mr G J Watson, Department of Otolaryngology, Head and Neck Surgery, Queen Elizabeth Hospital, Birmingham B15 2TH, UK E-mail:


Hide All
1Schuknecht, HF. Ablation therapy in the management of Meniere's disease. Acta Otolaryngol Suppl 1957;132:142
2Schoendorf, J, Neugebauer, P, Michel, O. Continuous intratympanic infusion of gentamicin via a microcatheter in Meniere's disease. Otolaryngol Head Neck Surg 2001;124:203–7
3Silverstein, H, Arruda, J, Rosenberg, SI, Deems, D, Hester, TO. Direct round window membrane application of gentamicin in the treatment of Meniere's disease. Otolaryngol Head Neck Surg 1999;120:649–55
4Thomsen, J, Charabi, S, Tos, M. Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere's disease. Eur Arch Otorhinolaryngol 2000;257:362–5
5Chia, SH, Gamst, AC, Anderson, JP, Harris, JP. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol 2004;25:544–52
6Fowler, EP Jr.Streptomycin treatment of vertigo. Trans Am Acad Ophthalmol Otolaryngol 1948;52:293301
7Beck, C, Schmidt, CL. 10 years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Meniere. Arch Otorhinolaryngol 1978;221:149–52
8Pullens, B, van Benthem, PP. Intratympanic gentamicin for Meniere's disease or syndrome. Cochrane Database Syst Rev 2011;(3):CD008234.
9Carey, J. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo. Otolaryngol Clin North Am 2004;37:1075–90
10Cohen-Kerem, R, Kisilevsky, V, Einarson, TR, Kozer, E, Koren, G, Rutka, JA. Intratympanic gentamicin for Meniere's disease: a meta-analysis. Laryngoscope 2004;114:2085–91
11Casani, AP, Piaggi, P, Cerchiai, N, Seccia, V, Franceschini, SS, Dallan, I. Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg 2012;146:430–7
12De Beer, L, Stokroos, R, Kingma, H. Intratympanic gentamicin therapy for intractable Meniere's disease. Acta Otolaryngol 2007;127:605–12
13Quaglieri, S, Gatti, O, Rebecchi, E, Manfrin, M, Tinelli, C, Mira, E et al. Intratympanic gentamicin treatment ‘as needed’ for Meniere's disease. Long-term analysis using the Kaplan-Meier method. Eur Arch Otorhinolaryngol 2014;271:1443–9
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed